DailyStocks Stock Article Search

https://www.cnbc.com/2024/01/31/you-hear-the-market-expects-six-fed-rate-cuts-this-year-heres-where-that-data-comes-from.html Jan 31, 2024 - When you hear about the number of Federal Reserve interest rate cuts being priced into the market, the data comes from the CME FedWatch tool. 0

https://www.zacks.com/stock/news/2218727/is-six-flags-entertainment-six-a-great-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2218727 Jan 31, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. 0

https://seekingalpha.com/news/4063208-ge-healthcare-stock-climbs-q4-beat?source=feed_sector_healthcare Feb 06, 2024 - GE HealthCare (GEHC) saw a 12% increase in its stock price after reporting stronger-than-anticipated Q4 2023 financial results. Read more here. 0

https://www.zacks.com/stock/news/2224242/mgm-resorts-mgm-to-report-q4-earnings-what-s-in-the-cards?cid=CS-ZC-FT-analyst_blog|earnings_preview-2224242 Feb 09, 2024 - MGM Resorts' (MGM) fourth-quarter top line is likely to have gained from increased business volume and travel activity at MGM China. 0

https://seekingalpha.com/article/4669253-us-ipo-weekly-recap-autoimmune-biotech-kyverna-therapeutics-gains-37-percent-in-a-6-ipo-week?source=feed_tag_ipo_analysis Feb 10, 2024 - Autoimmune disease biotech Kyverna Therapeutics (KYTX) priced above the upwardly revised range to raise $319 million at a $971 million market cap. 0

https://www.zacks.com/stock/news/2225390/what-s-in-store-for-penn-entertainment-penn-in-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2225390 Feb 13, 2024 - PENN Entertainment's (PENN) fourth-quarter 2023 results are likely to reflect benefits from solid growth of gaming revenues. 0

https://www.zacks.com/stock/news/2228024/live-nation-lyv-gears-up-for-q4-earnings-what-s-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2228024 Feb 19, 2024 - Live Nation's (LYV) fourth-quarter 2023 results are likely to reflect the impacts of an increase in demand for live events, a rise in average per-fan spending and a hike in ticket pricing. 0

https://www.zacks.com/stock/news/2228023/factors-setting-the-tone-for-choice-hotels-chh-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2228023 Feb 19, 2024 - Strong booking trends, continuous expansion through acquisitions and franchise agreements are likely to be reflected in Choice Hotels' (CHH) Q4 performance. 0

https://www.zacks.com/stock/news/2229515/what-s-in-the-offing-for-planet-fitness-plnt-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2229515 Feb 21, 2024 - Planet Fitness' (PLNT) fourth-quarter 2023 performance is likely to reflect benefits from the rise in membership sign-ups, strategic partnerships and international expansion. 0

https://www.fool.com/investing/2024/02/28/24-top-stocks-to-buy-now-in-march-2024/?source=iedfolrf0000001 Feb 28, 2024 - This list of specular stocks includes growth stocks, dividend stocks, and, perhaps best of all, artificial intelligence stocks. 0